Anti-Cleaved Caspase-3 antibody [E83-77] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(9 제품이 사용된 논문 )
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cleaved Caspase-3 antibody [E83-77] - BSA and Azide free (AB208003)
ab32042, at dilution of 1/100, staining HeLa cells by Immunofluorescence.
Left image : control.
Right image : staurosporine treated. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32042).
- WB
Supplier Data
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] - BSA and Azide free (AB208003)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32042). Anti-CASP3 antibody [E83-77] (ab32042) staining at 1/500 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab32042 was shown to bind specifically to CASP3. A band was observed at 16/28 kDa in treated wild-type HeLa cell lysates with no signal observed at this size in CASP3 knockout cell line. To generate this image, wild-type and CASP3 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (<a href='/ko/products/primary-antibodies/cleaved-caspase-3-antibody-e83-77-ab32042'>ab32042</a>) at 1/500 dilution
Lane 1:
Wild-type HeLa Treated Staurosporine (2uM, 4h) cell lysate at 20 µg
Lane 2:
CASP3 knockout HeLa Treated Staurosporine (2uM, 4h) cell lysate at 20 µg
Lane 3:
Wild-type HeLa Vehicle Control Staurosporine (0uM, 4h) cell lysate, at 20 µg
Lane 4:
CASP3 knockout HeLa Vehicle Control Staurosporine (0uM, 4h) cell lysate at 20 µg
Predicted band size: 32 kDa
Observed band size: 16 kDa,28 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-Cleaved Caspase-3 antibody [E83-77]
Reactivity 정보
제품 세부 정보
ab208003 is the carrier-free version of ab32042.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caspase 3 acts as an executioner enzyme in the process of programmed cell death. Its cleavage from the inactive zymogen form into the active form triggers apoptotic pathways ensuring the removal of damaged or unnecessary cells. Cleaved caspase operates within a proteolytic cascade often in conjunction with other caspases such as caspase 9. Once activated caspase 3 targets and cleaves specific cellular substrates contributing to the characteristic morphological changes and DNA fragmentation associated with apoptosis.
Pathways
Cleaved caspase 3 is significant within the intrinsic and extrinsic apoptotic pathways. It acts downstream of initiator caspases such as caspase 9 in the intrinsic pathway where its activation involves mitochondrial signals. In the extrinsic pathway it closely associates with caspase 8 mediating cell death signals from extracellular triggers. These pathways ensure that cleaved caspase 3 fulfills its role as a critical mediator of apoptosis linking upstream death signals to cellular dismantling during the apoptosis process.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (9)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Pakistan journal of pharmaceutical sciences 38:1632-1646 PubMed40996179
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:18586 PubMed39127716
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedical engineering online 21:53 PubMed35918704
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 26:3153-3168 PubMed35322540
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:783213 PubMed35095494
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 17:e1009834 PubMed34644293
2021
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 49:79-89 PubMed32048412
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 383:111505 PubMed31326389
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 37:157 PubMed30016965
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com